Enovis (ENOV) Total Debt (QoQ) (2011 - 2026)
Enovis (ENOV) Total Debt (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Enovis | 1.60 Bn | 1.57 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 2.25% |
| Dec 31, 2025 | -6.00% |
| Oct 3, 2025 | -1.01% |
| Jul 4, 2025 | 0.43% |
| Apr 4, 2025 | 2.82% |
| Dec 31, 2024 | 0.30% |
| Sep 27, 2024 | -1.03% |
| Jun 28, 2024 | 0.06% |
| Mar 29, 2024 | 191.46% |
| Dec 31, 2023 | 18.02% |
| Sep 29, 2023 | -1.25% |
| Jun 30, 2023 | 40.35% |
| Mar 31, 2023 | 9.92% |
| Dec 31, 2022 | -71.14% |
| Sep 30, 2022 | -0.05% |
| Jul 1, 2022 | -63.93% |
| Apr 1, 2022 | 19.03% |
| Dec 31, 2021 | 28.78% |
| Oct 1, 2021 | 1.82% |
| Jul 2, 2021 | -45.62% |